Trump’s Controversial Move: Cuts HIV Funding for Nigeria, Developing Nations – Landslide News
  • Latest
  • Trending
  • All
  • Business
  • Politics
  • Global
  • Lifestyle
  • Tech

Trump’s Controversial Move: Cuts HIV Funding for Nigeria, Developing Nations

January 28, 2025

APC Dismisses N800bn Claim Against Uzodimma

May 14, 2026

Presidential Fleet Gulps N4.24bn in 6Months

May 14, 2026

Dangote rejects NNPC Stake Increase Bid

May 14, 2026

PDP Denies APC Alliance, Says Party Is Focused on Winning 2027 Elections

May 13, 2026

Dele Momodu Defends Atiku’s 2027 Ambition

May 13, 2026

APC Crisis Deepens as Over 150 Aspirants Fail Screening

May 13, 2026

Zimbabwe Unveil 23-Man Squad for Unity Cup in London

May 12, 2026

Osimhen Declares Bassey Africa’s Best Defender

May 12, 2026

Hamstring Injury Puts Iwobi’s Return in Doubt

May 12, 2026

Gusau Raises Alarm Over Nigeria’s Stadium Infrastructure Gap

May 12, 2026

Release Nasir El-Rufai Buhari Ex-Aide to FG

May 12, 2026

Enekwechi Ruled Out of Title Defence in Accra

May 12, 2026
Landslide News
  • Home
  • Breaking News
  • Global
  • Business
  • Entertainment
    • Movies
    • Music
  • Fashion
  • Health
  • Lifestyle
  • Politics
  • Sports
  • Advertise
Create a Channel
No Result
View All Result
Landslide News
  • Home
  • News Insights @ LandslideNews
  • Breaking News
  • Politics
  • Global
  • Business
  • Entertainment
    • Movies
    • Music
  • Fashion
  • Health
  • Lifestyle
  • Sports
  • Tech
  • Advertise

Trump’s Controversial Move: Cuts HIV Funding for Nigeria, Developing Nations

byVictory Amah
January 28, 2025
in Business, Global, Health
15
Share on FacebookShare on Twitter

The US government has recently decided to halt its support for HIV treatment in Nigeria and other developing countries, following an order issued by President Donald Trump. This decision has significant implications for the health and well-being of millions of individuals who rely on these services. The US State Department has stopped the disbursement of funds from the President’s Emergency Plan for AIDS Relief (PEPFAR) for at least 90 days. This move stems from President Trump’s executive order on foreign aid, which he signed on his first day in office.

The executive order mandated that all government agencies involved in managing foreign development assistance programs cease distributing funds. Consequently, nearly all US global health funding was halted immediately, creating a ripple effect that threatens vital health services. Reports from NPR indicate that PEPFAR has stopped disbursing its funding and may need to suspend operations for at least three months unless an exemption is granted for the program shortly.

PEPFAR, which boasts an annual budget of $6.5 billion, has played a crucial role in delivering HIV/AIDS treatment to more than 20.6 million people. This program has not only saved countless lives but has also been instrumental in curbing the spread of the virus across the continent. According to a fact sheet from the US State Department, PEPFAR has been credited with saving the lives of an estimated 26 million people since it was established. However, in light of the recent ban, the agency expressed a firm stance, stating, “The United States is no longer going to blindly dole out money with no return for the American people.”

Public health experts are expressing deep concerns that the new Trump administration might ultimately terminate the entire PEPFAR program, which would have devastating effects on global health, particularly in regions heavily impacted by HIV. There is, however, a glimmer of hope among some advocates, particularly with Marco Rubio’s appointment as Secretary of State, as he has shown past support for the initiative.

In Nigeria, approximately two million people are currently living with HIV, many of whom benefit from the services provided by PEPFAR. As one of the countries with the highest HIV burden in the world, Nigeria relies heavily on programs like PEPFAR for access to life-saving medications and essential healthcare infrastructure support. Over the years, PEPFAR has contributed more than $6 billion to bolster Nigeria’s national HIV/AIDS response. Therefore, the suspension or potential permanent halt of this program is likely to have a severe impact on efforts to control and manage HIV in Nigeria, jeopardizing the health and lives of many individuals who depend on these critical services.

Share198Tweet124
Victory Amah

Victory Amah

Related Posts

Presidential Fleet Gulps N4.24bn in 6Months

byRosemary Ani Pius
2 days ago
0

Fresh disclosures from GovSpend, a platform that tracks public spending, show that no less than N4.24bn was released for the...

Dangote rejects NNPC Stake Increase Bid

byRosemary Ani Pius
2 days ago
0

President of the Dangote Group, Aliko Dangote, has revealed that the company turned down attempts by the Nigerian National Petroleum...

Pilots, Engineers Alert Over Aviation Fuel Shortage

byRosemary Ani Pius
5 days ago
0

The National Association of Aircraft Pilots and Engineers (NAAPE) has raised strong concerns over the continuing scarcity of aviation fuel,...

NMDPRA moves to boost fuel supply

byRosemary Ani Pius
1 week ago
0

Nigeria’s Senate has approved the appointment of Rabiu Umar as the substantive head of the Nigerian Midstream and Downstream Petroleum...

Comments 15

  1. Зареструватися says:
    1 year ago

    Your point of view caught my eye and was very interesting. Thanks. I have a question for you.

    Reply
  2. binance Code says:
    1 year ago

    Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

    Reply
  3. registro na binance says:
    1 year ago

    Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

    Reply
  4. binance says:
    1 year ago

    Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

    Reply
  5. Създаване на профил в binance says:
    12 months ago

    Your point of view caught my eye and was very interesting. Thanks. I have a question for you.

    Reply
  6. binance register says:
    11 months ago

    Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

    Reply
  7. binance says:
    11 months ago

    Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

    Reply
  8. Реферальный код binance says:
    10 months ago

    Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

    Reply
  9. Dang k'y www.binance.com says:
    10 months ago

    I don’t think the title of your article matches the content lol. Just kidding, mainly because I had some doubts after reading the article.

    Reply
  10. binance konto says:
    10 months ago

    Your article helped me a lot, is there any more related content? Thanks!

    Reply
  11. Buka Akun Binance says:
    9 months ago

    Thank you for your sharing. I am worried that I lack creative ideas. It is your article that makes me full of hope. Thank you. But, I have a question, can you help me?

    Reply
  12. Register says:
    8 months ago

    Thanks for sharing. I read many of your blog posts, cool, your blog is very good.

    Reply
  13. binance says:
    7 months ago

    I don’t think the title of your article matches the content lol. Just kidding, mainly because I had some doubts after reading the article.

    Reply
  14. binance Препоръчителство says:
    4 months ago

    Thanks for sharing. I read many of your blog posts, cool, your blog is very good. https://www.binance.info/register?ref=IXBIAFVY

    Reply
  15. binance Registrera says:
    1 month ago

    Can you be more specific about the content of your article? After reading it, I still have some doubts. Hope you can help me.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.